Compare SKLZ & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SKLZ | NSPR |
|---|---|---|
| Founded | 2012 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.0M | 81.8M |
| IPO Year | N/A | N/A |
| Metric | SKLZ | NSPR |
|---|---|---|
| Price | $5.73 | $1.85 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $14.00 | $4.50 |
| AVG Volume (30 Days) | 53.0K | ★ 187.0K |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $92,256,000.00 | $7,779,000.00 |
| Revenue This Year | $13.33 | $22.76 |
| Revenue Next Year | $12.68 | $75.45 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 14.04 |
| 52 Week Low | $3.54 | $1.59 |
| 52 Week High | $9.11 | $3.80 |
| Indicator | SKLZ | NSPR |
|---|---|---|
| Relative Strength Index (RSI) | 46.02 | 44.34 |
| Support Level | $5.27 | $1.80 |
| Resistance Level | $5.87 | $1.93 |
| Average True Range (ATR) | 0.28 | 0.14 |
| MACD | 0.09 | 0.00 |
| Stochastic Oscillator | 80.99 | 43.80 |
Skillz Inc is a mobile game development company. It is engaged in re-inventing competitive mobile gaming and thereby expanding the mobile gaming market. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube among others. The company's reportable business segments are; the Skillz segment and the Aarki segment. The majority of its revenue is generated from the Skillz segment which is an eSports gaming platform, enabling game developers to monetize their content through multi-player competition. Geographically, the company derives its key revenue from the United States and the rest from Israel, China, Malta, and other countries.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.